Back to companies

Cytokinetics Inc: Segment Analysis

Business Description

Cytokinetics Inc (Cytokinetics) discovers, develops and commercializes muscle activators and inhibitors for the treatment of muscle function disorder in cardiovascular and neuromuscular diseases.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

The company’s R&D activities focus on the development of drug candidates for the treatment of muscle function disorder. It conducts muscle contractility research through its cardiac muscle contractility and skeletal muscle contractility program. Its cardiac muscle contractility program focuses on cardiac sarcomere, a basic unit of muscle contraction in the heart and the skeletal muscle contractility program focuses on the activation of the skeletal sarcomere, the basic unit of skeletal muscle contraction. In FY2021, the company incurred expenses of US$159.9 million on its R&D activities. Through research collaborations with Amgen and Astellas, Cytokinetics advances its muscle biology programs. The company intends to advance its business by seeking patent protection for the technologies, inventions and improvements. As of December 31, 2021, the company owned or licensed 74 issued US patents, over 620 issued patents in various countries and over 320 additional pending US and foreign patent applications.



Other Break-up

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Get started with Company Analytics for access to other break-up segment data Get started with Company Analytics for access to other break-up segment data Learn More

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer